A carregar...
Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is increasing worldwide and is predicted to become the third most frequent cause of death by 2030. Muscarinic receptor antagonists, alone or in combination with long-acting β2-agonists, are frequently used for COPD therapy. Aclidinium bromide is a novel m...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063860/ https://ncbi.nlm.nih.gov/pubmed/24966682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S39710 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|